Issue Highlights

Anti-tumor necrosis factor (TNF) biologics are an important class of treatment in patients with inflammatory bowel disease.1 Because of population aging and improved therapeutics, clinicians are seeing more elderly patients with indications for anti-TNF therapy. It is thus important to evaluate the safety and efficacy of these agents in the elderly population.2
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Issue Highlights Source Type: research